FDA: Adverse Events Associated With Compounded Steroid Injections

Last week the Food and Drug Administration alerted healthcare providers of seven adverse events associated with steroid injections compounded at Main Street Family Pharmacy in Newbern, Tenn.

Advertisement

Further detail on the adverse events was not provided, but were all from patients who received preservative free methylprednisolone acetate (80 mg/mL) by injection, according to the FDA.

The FDA has recommended providers not administer any products from Main Street until further guidance is provided.

More Articles on Compounding Pharmacy Contamination:

FDA Warns Drugs From Florida Compounding Shop May Be Contaminated
New Sterile Compounding Guidelines Released

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.